Lipocalin homolog
US6020163A · kind A · utility
34Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 6, 1998 |
| Grant date | Feb 1, 2000 |
| Priority date | — |
| Expiry date | Aug 6, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to polynucleotides and polypeptides for a novel member of the lipocalin family. The expression of this novel polynucleotide is restricted to testis and mammary gland, particularly breast tumor tissue. The polypeptide has been designated zlipo1. The present invention also includes antibodies to the zlipo1 polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.